UNDERWRITING AGREEMENTUnderwriting Agreement • December 4th, 2018 • Inspire Medical Systems, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledDecember 4th, 2018 Company Industry Jurisdiction
KARYOPHARM THERAPEUTICS INC. (a Delaware corporation) 3,902,439 Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • April 26th, 2017 • Karyopharm Therapeutics Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 26th, 2017 Company Industry Jurisdiction
UNDERWRITING AGREEMENTUnderwriting Agreement • January 20th, 2015 • Tracon Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledJanuary 20th, 2015 Company Industry JurisdictionTRACON Pharmaceuticals, Inc., a Delaware corporation (the “Company”) confirms its agreement with Wells Fargo Securities, LLC (“Wells Fargo”), Stifel, Nicolaus & Company, Incorporated (“Stifel”) and each of the other Underwriters named in Exhibit A hereto (collectively, the “Underwriters,” which term shall also include any underwriter substituted as hereinafter provided in Section 10 hereof), for whom Wells Fargo and Stifel are acting as representatives (in such capacity, the “Representatives”), with respect to the issue and sale by the Company of a total of [·] shares (the “Initial Securities”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and the purchase by the Underwriters, acting severally and not jointly, of the respective numbers of Initial Securities set forth in said Exhibit A hereto, and with respect to the grant by the Company to the Underwriters, acting severally and not jointly, of the option described in Section 2(b) hereof to purchase all
UNDERWRITING AGREEMENT1Underwriting Agreement • September 16th, 2014 • ProQR Therapeutics B.V. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 16th, 2014 Company Industry Jurisdiction